<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6"><gtr:id>0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6</gtr:id><gtr:name>Hebrew University of Jerusalem</gtr:name><gtr:address><gtr:line1>Mt Scopus</gtr:line1><gtr:line4>Jerusalem</gtr:line4><gtr:line5>91905</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF06ABFB-9547-484C-84F9-4110ED8759B7"><gtr:id>BF06ABFB-9547-484C-84F9-4110ED8759B7</gtr:id><gtr:name>Manchester University NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Central Manchester University Hospitals NHS Foundation Trust,Manchester Royal Infirmary,Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/395F850A-031E-45AD-817A-4C46D042B92C"><gtr:id>395F850A-031E-45AD-817A-4C46D042B92C</gtr:id><gtr:name>University of Cincinnati</gtr:name><gtr:address><gtr:line1>University of Cincinnati</gtr:line1><gtr:line2>2624 Clifton Avenue</gtr:line2><gtr:postCode>OH 45221-0</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8C250FB6-4890-4BF9-9C23-69E6B2E02B95"><gtr:id>8C250FB6-4890-4BF9-9C23-69E6B2E02B95</gtr:id><gtr:name>Wake Forest University</gtr:name><gtr:address><gtr:line1>Wake Forest University</gtr:line1><gtr:line2>1834 Wakeforest Road</gtr:line2><gtr:line4>Winston Salem</gtr:line4><gtr:line5>North Carolina</gtr:line5><gtr:postCode>NC 27106</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6"><gtr:id>0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6</gtr:id><gtr:name>Hebrew University of Jerusalem</gtr:name><gtr:address><gtr:line1>Mt Scopus</gtr:line1><gtr:line4>Jerusalem</gtr:line4><gtr:line5>91905</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF06ABFB-9547-484C-84F9-4110ED8759B7"><gtr:id>BF06ABFB-9547-484C-84F9-4110ED8759B7</gtr:id><gtr:name>Manchester University NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Central Manchester University Hospitals NHS Foundation Trust,Manchester Royal Infirmary,Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/395F850A-031E-45AD-817A-4C46D042B92C"><gtr:id>395F850A-031E-45AD-817A-4C46D042B92C</gtr:id><gtr:name>University of Cincinnati</gtr:name><gtr:address><gtr:line1>University of Cincinnati</gtr:line1><gtr:line2>2624 Clifton Avenue</gtr:line2><gtr:postCode>OH 45221-0</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8C250FB6-4890-4BF9-9C23-69E6B2E02B95"><gtr:id>8C250FB6-4890-4BF9-9C23-69E6B2E02B95</gtr:id><gtr:name>Wake Forest University</gtr:name><gtr:address><gtr:line1>Wake Forest University</gtr:line1><gtr:line2>1834 Wakeforest Road</gtr:line2><gtr:line4>Winston Salem</gtr:line4><gtr:line5>North Carolina</gtr:line5><gtr:postCode>NC 27106</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FFADE489-5C2F-4860-A8CC-16981824D4E3"><gtr:id>FFADE489-5C2F-4860-A8CC-16981824D4E3</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Holgate</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G19%2F34"><gtr:id>CCC3E7D5-1730-4F08-987F-6B378AE6495C</gtr:id><gtr:title>MRC Clinical Research Professorship</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G19/34</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>256855</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Manchester Academic Health Science Centre</gtr:department><gtr:description>Translational medicine at Manchester</gtr:description><gtr:id>B149691E-8253-437C-8FA6-5DF10E4B1FB9</gtr:id><gtr:impact>Appointment of a new Chair in Translational Medicine</gtr:impact><gtr:outcomeId>GgtvCKWqjrv-2</gtr:outcomeId><gtr:partnerContribution>It has been largely my helping them.</gtr:partnerContribution><gtr:piContribution>Helped Manchester University shape and prioritise its translational medicine programmes. I was awarded a 3 year Visiting Professorship to do this</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hebrew University of Jerusalem</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>CD48 as a novel therapeutic target for asthma</gtr:description><gtr:id>3BFF1BBB-A03E-405C-9FF1-57DDC6515227</gtr:id><gtr:impact>We have already discussed development of blocking mAbs against CD48 with MRCT. They requested further validation which we are undertaking.</gtr:impact><gtr:outcomeId>mX4NUmdsNxA-1</gtr:outcomeId><gtr:partnerContribution>They have identified the target and we are assisting in validating it in human disease.</gtr:partnerContribution><gtr:piContribution>We are exploring the role of CD48 as a key regulator of mast cell and eosinophil function in collaboration with Prof Franesco Levi-Schaffer.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Melbourne</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Meigunyah Destinguished Visiting Fellowship</gtr:description><gtr:id>E4923DBB-E7C6-47D7-934F-88A660C0B230</gtr:id><gtr:impact>None at present but anticipated</gtr:impact><gtr:outcomeId>iMiGXX38Gbp-1</gtr:outcomeId><gtr:partnerContribution>We have been working together to launch a nw Lung Centre in Melbourne, This will be anounced at the Public Lecture which is part of this Fellowship.</gtr:partnerContribution><gtr:piContribution>Although the innitial collaboration with Professors Alastair Stewart and Garry Anderson, began 1n 2010, the award to me of this prestigeous Fellowship is enabling collaborative reserch and staff exchange with the University of Melbourne</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wake Forest University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Genetics</gtr:department><gtr:description>Genetics of asthma</gtr:description><gtr:id>4E27D1E0-0DE6-4D12-84C5-2DE818A70264</gtr:id><gtr:impact>Participation in a grant proposal in MRC Strastified Medicine Innitiative.</gtr:impact><gtr:outcomeId>YdaACHiBvcx-2</gtr:outcomeId><gtr:partnerContribution>Intellectual, exchange visits and exchange of clinical data and samples for genetic studies.Exchange of samples and clinical data</gtr:partnerContribution><gtr:piContribution>Collaboration relating to data and sample exchange</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of East Anglia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine UEA</gtr:department><gtr:description>Norwich Medical School</gtr:description><gtr:id>4A217B91-11A8-443F-95E1-33A85224ED3F</gtr:id><gtr:impact>Reports to Medical School</gtr:impact><gtr:outcomeId>tBFth5AAxqa-1</gtr:outcomeId><gtr:partnerContribution>One way at present</gtr:partnerContribution><gtr:piContribution>Member of the Med Sch Scientific Advisory Board (Chair Sir Nicholas Wright)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cincinnati</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Respiratory Research Cincinnati</gtr:department><gtr:description>Genetic control of asthma</gtr:description><gtr:id>0EDBBC7E-DE75-4F39-8E0A-6EBB13DEA925</gtr:id><gtr:impact>Publications.</gtr:impact><gtr:outcomeId>J2Pn43wXkU8-1</gtr:outcomeId><gtr:partnerContribution>Helped us develop tradgenic mice for ADAM33 and epithelial research in asthma</gtr:partnerContribution><gtr:piContribution>Generated conditional gene manipulated mice (via an MRC Clinician Scientist award)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Molecular Medical Sciences Nottingham</gtr:department><gtr:description>Asthma genetics</gtr:description><gtr:id>94D06381-56C7-42CD-A28B-403877D5EE70</gtr:id><gtr:impact>Joint publications; 19443020</gtr:impact><gtr:outcomeId>3F8DA9BF453-1</gtr:outcomeId><gtr:partnerContribution>Joint publication</gtr:partnerContribution><gtr:piContribution>Novel asthma genes;</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Manchester University NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Respiratory Clinical Research Centre, Wythenshawe</gtr:department><gtr:description>Clinical trial of interferon beta in asthma</gtr:description><gtr:id>A90E1097-626C-463F-8624-312BFB7D237F</gtr:id><gtr:impact>Trial still in progress</gtr:impact><gtr:outcomeId>dmXkfECr4Zt-1</gtr:outcomeId><gtr:partnerContribution>Professor Woodcock and colleagues are conducting a clinical trial funded by our company Synairgen</gtr:partnerContribution><gtr:piContribution>Identification of a lesion of beta interferon deficiency in asthmatic airways. Repacement with inhaled beta interferon in progress as a Phase 2 Clinical Trial.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wake Forest University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Genetics</gtr:department><gtr:description>Genetics of asthma</gtr:description><gtr:id>68041091-0E46-4D46-AE88-AD8410E7541C</gtr:id><gtr:impact>Participation in a grant proposal in MRC Strastified Medicine Innitiative.</gtr:impact><gtr:outcomeId>YdaACHiBvcx-1</gtr:outcomeId><gtr:partnerContribution>Intellectual, exchange visits and exchange of clinical data and samples for genetic studies.Exchange of samples and clinical data</gtr:partnerContribution><gtr:piContribution>Collaboration relating to data and sample exchange</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wake Forest University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Centre for Genomics and Personalised Medicine Research</gtr:department><gtr:description>Asthma genetics with Profs Meyers and Bleecker, Wake Forest University</gtr:description><gtr:id>11F72840-8E47-4CD9-83A5-804DCCB295BD</gtr:id><gtr:impact>Review in press in Lancet respiratory medicine
Sessions at the ERS, EAACI and ATS Congresses</gtr:impact><gtr:outcomeId>pXjXDfqWjqe-1</gtr:outcomeId><gtr:partnerContribution>Collaboration for research and exchange of materials</gtr:partnerContribution><gtr:piContribution>Collaboration for research and exchange of materials</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Groningen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Asthma genetics</gtr:description><gtr:id>D0EB9FE6-3D7F-4364-B6FB-0BAF372365B0</gtr:id><gtr:impact>Publications 19729670 . Also a long term relationship between Southampton and Groningen on PhD student exchanges.</gtr:impact><gtr:outcomeId>0C8DCEABFB8-1</gtr:outcomeId><gtr:partnerContribution>Joint studentship exchange.</gtr:partnerContribution><gtr:piContribution>Novel genes identified associated with asthma.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Founded the National Allergy Strategy Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>89EC4228-B92D-4B62-9074-DF9613799F63</gtr:id><gtr:impact>Created a unique Group for proffessionals (BSACI) and charities (Allergy UK, the Allergy Alliance, Anaphylaxis Campaign) to join forces to promote better allergy provisionin the UK

House of Lords S &amp;amp; T Committee Review of Allergy Services and formation of a Commissioning Group.</gtr:impact><gtr:outcomeId>06AE036FE46</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Established All Party Parliamentary Group on Allergy</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>297E3F1D-34CA-42F2-A444-4AECD273C8F2</gtr:id><gtr:impact>NASG has founded this Group to interact with parliamentarians over improved allergy provision

Allergy now recognised as a public health problem.</gtr:impact><gtr:outcomeId>612C472D1B1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multiple interactions with the local and national press</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>47D7E16F-42FA-4A7A-9E34-EF5FA2FF69AF</gtr:id><gtr:impact>I am frequently contacted by the press, radio and TV for interviews relating to asthma and allergy.

Publication in the lay press and attraction of funding to our charity AAIR</gtr:impact><gtr:outcomeId>16A81A7B6B3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Established United Kingdom Respiratory Research Collaborative.</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>2A9E7841-8E42-4FE6-80B0-58431CFB3B05</gtr:id><gtr:impact>A multiproffesional interaction to promote greater lung-related research in the UK (Founding Chair)

Since 2005 3-fold increase in success rate of lung research funding including MRC.</gtr:impact><gtr:outcomeId>BD72479B5AF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medicine and Me Conferences at RSM</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>68331B98-E907-434F-8DD9-D0C8ACFFEF8A</gtr:id><gtr:impact>I have participated actively in 3 RSM Patient Medicine and Me Conferences (Asthma, Allergy, CFS)

Greater awareness of the diseases and their management.</gtr:impact><gtr:outcomeId>861F65A0CB0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Established AAIR Charity (Founder)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>F1BA2ED2-2C7A-46FC-BA8F-B5347DDFE024</gtr:id><gtr:impact>Multiple interactions at public lectures and schools; charitable fund raising activities also.

Active fund raising by the public for the Charity and to raise awareness of asthma</gtr:impact><gtr:outcomeId>1C44BECABEF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EU Parliament : Brussels Declaration on Asthma.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>CC192DBF-9337-48DF-9A9E-BB886B4F5ABB</gtr:id><gtr:impact>Wporked with an MEP to bring together patient organisations, professionals and the industry to agree new and needed directions for asthma management.

Influennce over Management Guidelines.</gtr:impact><gtr:outcomeId>1DE59E20996</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MP visits to the laboratory</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>7F1A5EC5-CBCA-429E-BA19-6F6A9D4B4243</gtr:id><gtr:impact>Our local MPs have visited our laboratories on a number of occasions.

Representation of views in Parliament.</gtr:impact><gtr:outcomeId>C20A222022C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>President of the British Thoracic Society</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>FAA29517-98AF-4B91-990F-284C595C503B</gtr:id><gtr:impact>As President of the BTS I promulgated research findings and promoted lung research to many different professionals.

Greater awareness of lung diseases</gtr:impact><gtr:outcomeId>82F85D4C70C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Charity Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>55305154-281A-4D92-B2BF-C5E4362445D0</gtr:id><gtr:impact>Uptake of more individuals into Clinical Trials

Local input into press</gtr:impact><gtr:outcomeId>Xp3jBUXnksz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Capacity Buildiing Studentship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>57077934-9C33-43AF-B43E-005203DFE89D</gtr:id><gtr:outcomeId>F41D6C814E80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1579270</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B2A904A7-D1BB-4344-81DB-CE2678218B8F</gtr:id><gtr:outcomeId>68BBEBC044C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinician Scientist</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6F9519FC-61F1-4A43-A520-3265DC54F67A</gtr:id><gtr:outcomeId>myvVFAaYrNs0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>992869</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinician Scientist</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0041527F-591F-4DE0-9CAE-55C73EB762B2</gtr:id><gtr:outcomeId>RZbrtwx73KH0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>01342EEE-E35F-449A-AC5E-61D3D687CD99</gtr:id><gtr:outcomeId>sL41joiXbmp0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentship (ITTP)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>68D79AE1-C0D2-4699-8B33-7A9D89D85732</gtr:id><gtr:outcomeId>0B2CB0E55EA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>675116</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8E845467-FA4C-4BC9-961F-6F69A635999D</gtr:id><gtr:outcomeId>hq7JiQi5aDv0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Southampton Respiratory Biomedical Research Centre</gtr:department><gtr:description>NIHR Biomedical Research Unit (Respiratory Disease)</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>A4C33956-EB2F-4A11-9834-D8495D0AD43A</gtr:id><gtr:outcomeId>rot2RxbzNYo0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>298000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3R's Project Grant</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>86D8BBC8-6629-463F-8CF2-D036DA2DE691</gtr:id><gtr:outcomeId>49B81B7A1A10</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9981E2EC-86F9-480A-B438-F856870A55D1</gtr:id><gtr:outcomeId>411332A4C7D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Southampton Respiratory Biomedical Research Centre</gtr:department><gtr:description>NIHR Biomedical Research Unit (Respiratory Disease)</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>E438A1A8-389C-4CA9-9CDA-2A460A0186DB</gtr:id><gtr:outcomeId>WFrCyN8oMJE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>499713</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>172D45D4-DA54-483E-B3E7-AD8F5A6B5285</gtr:id><gtr:outcomeId>GEcBq4wbM3M0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>143553</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:id>0B720F55-C15C-401F-9E53-DCD665B06360</gtr:id><gtr:outcomeId>FWCUwDnoTZ30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>ANTI-VIRUS THERAPY FOR RESPIRATORY DISEASES: inhaled beta interferon for asthma exacerbations and COPD.</gtr:description><gtr:grantRef>G19/34</gtr:grantRef><gtr:id>0F0048AD-CEE1-411E-B90D-14299FA80F58</gtr:id><gtr:impact>Clinical Trial (Phase 2) in progress tpo be completed Dec 2011</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>nQkEStFzzML</gtr:outcomeId><gtr:patentId>WO2005087253</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Interferon beta in the treatment of exacerbations of asthma and COPD</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Inhaled interferon treatment in respiratory disese caused by viruses</gtr:description><gtr:grantRef>G19/34</gtr:grantRef><gtr:id>E86B392E-BFD1-4D02-8649-833AA2ED729D</gtr:id><gtr:impact>Clinical trials in progress with Synairgen</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>PRXCX2Yuqko</gtr:outcomeId><gtr:patentId>US 2007134763  (A1)</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Anti-virus therapy for respiratory diseases</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>INTERFERON-BETA FOR ANTI-VIRUS THERAPY FOR RESPIRATORY DISEASES</gtr:description><gtr:grantRef>G19/34</gtr:grantRef><gtr:id>127EEF3D-9D6E-4C09-A1EC-DDD20378D1C9</gtr:id><gtr:impact>Inhaled inteferon treatment of asthma and COPD</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>DKLrc5asgDF</gtr:outcomeId><gtr:patentId>WO2005087253</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>INTERFERON-BETA FOR ANTI-VIRUS THERAPY FOR RESPIRATORY DISEASES</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Inhaled interfron for asthma and COPD</gtr:description><gtr:grantRef>G19/34</gtr:grantRef><gtr:id>F2C5F6F6-49EC-4777-AF0F-9E3912793422</gtr:id><gtr:impact>Clinical trials in progress with Synairgen.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>JAo14u9NKBD</gtr:outcomeId><gtr:patentId>US7569216</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Anti-virus therapy for respiratory diseases</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Interfron by inhalation for lung diseases caused by viruses</gtr:description><gtr:grantRef>G19/34</gtr:grantRef><gtr:id>870B83B3-096F-4D16-915C-6D5B489B2246</gtr:id><gtr:impact>Clinical trials in progress with Synairgen.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>YBgnzqVLg3U</gtr:outcomeId><gtr:patentId>JP2011144201</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>INTERFERON-BETA FOR ANTI-VIRUS THERAPY FOR RESPIRATORY DISEASES</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Inhaled interferon for asthma and COPD</gtr:description><gtr:grantRef>G19/34</gtr:grantRef><gtr:id>427815D9-36E4-4B44-900C-389C99C67347</gtr:id><gtr:impact>Synairgen conducting clinical trials</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>NEjM7kQKAzv</gtr:outcomeId><gtr:patentId>HK1097181</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>INTERFERON-BETA FOR ANTI-VIRUS THERAPY FOR RESPIRATORY DISEASES</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Inhaled interferon beta for asthma and COPD exacerbations</gtr:description><gtr:grantRef>G19/34</gtr:grantRef><gtr:id>6227D06F-BEDD-4113-B40D-EE456D073A37</gtr:id><gtr:impact>Synairgen are conducting Phase 2 clinical trials.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>TzpJVcgsPyd</gtr:outcomeId><gtr:patentId>JP 2011144201  (A)</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>INTERFERON-beta FOR ANTI-VIRUS THERAPY FOR RESPIRATORY DISEASE</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Interferon treatment of asthma and COPD</gtr:description><gtr:grantRef>G19/34</gtr:grantRef><gtr:id>D0AC82E0-C6F4-4A06-9803-0E5055AA7D1B</gtr:id><gtr:impact>Synairgen conducting Phase 2 Clinical Trials. Now oulicensed to AZ ($230 million) see: http://www.synairgen.com/news/press-releases/2014/astrazeneca-licence-deal/</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>nTJ1US9Qomi</gtr:outcomeId><gtr:patentId>JP2007528890 ?</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>ANTI-VIRUS THERAPY FOR RESPIRATORY DISEASES</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Translational Medicine Board (OSCHR)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>601EA9CD-4996-496F-B8EA-6EF8F7625675</gtr:id><gtr:outcomeId>059BCC40F69</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisory Committeeon Novel Foods and Processes</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76DD5328-5004-44F3-8ACE-7466FE867748</gtr:id><gtr:impact>Protection of the public through regulation and labelling. I completed my term in 2014</gtr:impact><gtr:outcomeId>FC54A7559CC</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://acnfp.food.gov.uk/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Inflammation as underlying the need for controller drugs in asthma management</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Global Innitiative for Asthma</gtr:guidelineTitle><gtr:id>4F33FBFA-AF62-426B-8485-B4509B9D6D18</gtr:id><gtr:impact>Better asthma diagnosis and treatment.</gtr:impact><gtr:outcomeId>3777C39219A</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.ginasthma.org/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisory Committee for Hazardous Substances (ACHS, Defra)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>2BD696F1-6892-44A3-A156-6F110EA070CF</gtr:id><gtr:impact>Advice to Government and the public on chemical regulation.</gtr:impact><gtr:outcomeId>D6B2C03DDBD</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>https://www.gov.uk/government/groups/hazardous-substances-advisory-committee</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Inflammation as the basis of asthma</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Asthma Management Guidelines 2008</gtr:guidelineTitle><gtr:id>3AD6E3C6-772A-4FC5-9817-89394A95CD21</gtr:id><gtr:impact>Better treatment of asthma.</gtr:impact><gtr:outcomeId>AC4383B954E</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.ginasthma.org/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advice to the Public on Acute Air Pollution Episodes</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>73B402F1-B12E-4F71-AD6C-0ACB0CE8E8DF</gtr:id><gtr:impact>We used new research to redefine the threholds for medical advice on air pollution episodes in the UK. This was a COMEAP Subgroup that I chaired.</gtr:impact><gtr:outcomeId>tgJYf4BRT1Q</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/304633/COMEAP_review_of_the_uk_air_quality_index.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Board of Management of the World Allergy Organisation.</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>BFCB255B-FA1B-43B9-937B-8F275FFBF805</gtr:id><gtr:impact>Many outputs, but mostly organising and advising on international activities in Allergy (including its recognition as a public healthy problem). After being a Board member for 4 years I was selected to be Treasurer that I did for a further 2 years before demitting.</gtr:impact><gtr:outcomeId>D913192936A</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.worldallergy.org/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the Royal Commission on Environmental Pollution</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>E0D485A3-830F-464C-9A99-99F464F2CC01</gtr:id><gtr:impact>10 Reports on a vast range of topics including chemicals, the urban environment, the oceons, pesticides, light pollution, biomass etc.</gtr:impact><gtr:outcomeId>573059D4F83</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.thenbs.com/PublicationIndex/Documents?Pub=RCEP</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Special Advisor to the HOLSC on S &amp;amp; T</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>421E94C5-96B8-40F4-9F38-0D68F4383CF5</gtr:id><gtr:impact>The Report will be published in Feb 2010.</gtr:impact><gtr:outcomeId>C6D2A821074</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type><gtr:url>http://www.publications.parliament.uk/pa/ld200910/ldselect/ldsctech/22/2202.htm</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Committee for the Medical Effects of Air Pollutants</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A9BC1B11-6069-41C2-8841-91ABBA032FBC</gtr:id><gtr:impact>Policy relating to Air Quality and advice to the public. I was Founder Chair for 15 years and then Chaired Defra's EPAQS that became subsumed into COMEAP as its Standards Quality Subgroup.</gtr:impact><gtr:outcomeId>3E50C1C3B45</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>https://www.gov.uk/government/groups/committee-on-the-medical-effects-of-air-pollutants-comeap</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Board Chair NC3Rs</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6AD2736B-51FC-40F1-8E7A-99ED5368E32F</gtr:id><gtr:impact>NC3Rs Board Chair appointed by interview. Help in setting the straegic diection of NC3Rs and implement the different grants panels and forms of funding (e.g.CrackIt)</gtr:impact><gtr:outcomeId>Fj2zDW3wcep</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>https://www.nc3rs.org.uk/about-us/board</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>RCP/RCPH Report on Air Pollution</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>27D4494B-6C3B-49EB-82DF-33B485040094</gtr:id><gtr:impact>This influential report has created new air quality initiatives in PHE, Defra and local authorities.</gtr:impact><gtr:outcomeId>58bd7e0a591577.96738248</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://www.rcplondon.ac.uk/projects/outputs/every-breath-we-take-lifelong-impact-air-pollution</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We founded Synairgen in 2005 with a subsequent launch on AIM. Our recent (2009) fund raising will provide resource to take us through Phase 2 for IFN in asthma, Copd exacerbations and influenzaandemics.</gtr:description><gtr:id>A9850C52-3274-4A21-8BFE-C7EC79322DD9</gtr:id><gtr:impact>A new therapy of inhalede IFN for asthma, COPD and influenza independant of drug resistence.</gtr:impact><gtr:outcomeId>40C3501F732</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Interferon beta</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2006</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Synairgen</gtr:companyName><gtr:description>Synairgen is a drug discovery and development company specialising in respiratory diseases with a focus on asthma and chronic obstructive pulmonary disease (COPD). It was spun out of the University of Southampton in 2003. A small lean and highly focused company to develop new respiratory drugs. Most of our effort is now focused on an inhaled formulation of IFN beta for treating severe virus-induced exacerbations of asthma and COPD as well as hospital-based influenza admissions.; http://www.synairgen.com/</gtr:description><gtr:id>5D3BD46F-EDC3-48EB-81CA-CB3B29B59E2A</gtr:id><gtr:impact>Successful preclinical and Phase 1 development of inhaled interferon beta for treatment of virus-induced asthma exacerbations. We are entering phase 2a for asthma and COPD indications after a successful 2nd fund raising round in early 2009.</gtr:impact><gtr:outcomeId>BEB04A79E65</gtr:outcomeId><gtr:url>http://www.synairgen.com</gtr:url></gtr:spinOutOutput><gtr:spinOutOutput><gtr:companyName>Synairgen</gtr:companyName><gtr:description>New treatments for asthma and COPD. 
http://www.synairgen.com/</gtr:description><gtr:id>504C8749-BB2E-41C9-90C4-5BEDF9F1C7E7</gtr:id><gtr:impact>In haled Interferon beta trials for asthma, COPD and influenza. Biomarkers and biobank</gtr:impact><gtr:outcomeId>VD45qNXUfz7</gtr:outcomeId><gtr:url>http://www.synairgen.com</gtr:url><gtr:yearCompanyFormed>2004</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>874EBB76-4572-4159-B879-D908828A5EE7</gtr:id><gtr:title>Genetics of allergic disease.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28951db76a9f81ac234722613fce9583"><gtr:id>28951db76a9f81ac234722613fce9583</gtr:id><gtr:otherNames>Holloway JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>ab7YPCooqMC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4726B608-DE61-41E4-BBC0-800B67DB03E0</gtr:id><gtr:title>Tumor necrosis factor alpha (TNF-a) autoregulates its expression and induces adhesion molecule expression in asthma.</gtr:title><gtr:parentPublicationTitle>Clinical immunology (Orlando, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd7bdb6bd19b3a45ae9ef0efe392106c"><gtr:id>cd7bdb6bd19b3a45ae9ef0efe392106c</gtr:id><gtr:otherNames>Babu SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1521-6616</gtr:issn><gtr:outcomeId>eMKqSSqMfo4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9270EF8-EDB1-43E8-A74E-5F839581FAC1</gtr:id><gtr:title>Exposure, uptake, distribution and toxicity of nanomaterials in humans.</gtr:title><gtr:parentPublicationTitle>Journal of biomedical nanotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1550-7033</gtr:issn><gtr:outcomeId>b32jN2C12Tv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B55FFACE-0DA2-4FE5-98B9-F4A3BE2191E0</gtr:id><gtr:title>The innate antiviral response upregulates IL-13 receptor a2 in bronchial fibroblasts.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c266e75a45719efdd289278d39101679"><gtr:id>c266e75a45719efdd289278d39101679</gtr:id><gtr:otherNames>Campbell-Harding G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_15040_20_23069489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0178A375-9925-470A-A918-5D8FABC604BD</gtr:id><gtr:title>Concentration response functions for ultrafine particles and all-cause mortality and hospital admissions: results of a European expert panel elicitation.</gtr:title><gtr:parentPublicationTitle>Environmental science &amp; technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09653cd32913d293829e1189adbec68e"><gtr:id>09653cd32913d293829e1189adbec68e</gtr:id><gtr:otherNames>Hoek G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-936X</gtr:issn><gtr:outcomeId>A76FE0F1E17</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C1B0BBE-4D14-40D9-9320-AE052C6693EE</gtr:id><gtr:title>Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in&amp;nbsp;vitro and in&amp;nbsp;vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de91105e42bdf267944b020828390242"><gtr:id>de91105e42bdf267944b020828390242</gtr:id><gtr:otherNames>Park JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_15040_20_22828416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA1F67AE-EA6F-47BB-9C4F-1E56F4E383DD</gtr:id><gtr:title>Asthma: a simple concept but in reality a complex disease.</gtr:title><gtr:parentPublicationTitle>European journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2972</gtr:issn><gtr:outcomeId>mRsepu3q1C8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75E64B61-1CAF-4938-9B79-366B9FA53F88</gtr:id><gtr:title>Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f59e58738a90493179d2cbcfa849c8f"><gtr:id>0f59e58738a90493179d2cbcfa849c8f</gtr:id><gtr:otherNames>Bousquet J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>JgZPGLNsQ9f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B478BA95-D594-48A9-8CB0-03AD2BA466EA</gtr:id><gtr:title>Driving asthma care in Europe: the Brussels Declaration.</gtr:title><gtr:parentPublicationTitle>Primary care respiratory journal : journal of the General Practice Airways Group</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f793806ac5b5cc5e7a6f7b0ca6ee3f4"><gtr:id>2f793806ac5b5cc5e7a6f7b0ca6ee3f4</gtr:id><gtr:otherNames>Haughney J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-4418</gtr:issn><gtr:outcomeId>5C632D35FC9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22EF7514-BFAB-4C22-9502-11391AEF7B85</gtr:id><gtr:title>The era of research collaborations: new models for working together.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d86690ebcc2d5e9359a3cc61c0e832ea"><gtr:id>d86690ebcc2d5e9359a3cc61c0e832ea</gtr:id><gtr:otherNames>Djukanovic R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>58bd7a15448690.00329154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>989F166C-DE19-411B-BF04-053ECACCFEEE</gtr:id><gtr:title>Frmd7 expression in developing mouse brain.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2eb240a61efb453289ad562ef16a39f"><gtr:id>f2eb240a61efb453289ad562ef16a39f</gtr:id><gtr:otherNames>Self J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>A573B1B0D73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60783173-CC2D-4D2C-AF1C-FBEDF25031AA</gtr:id><gtr:title>Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.</gtr:title><gtr:parentPublicationTitle>International archives of allergy and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2b214240f28257b982cc90f67711634"><gtr:id>b2b214240f28257b982cc90f67711634</gtr:id><gtr:otherNames>WHO Collaborating Center for Asthma and Rhinitis</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1018-2438</gtr:issn><gtr:outcomeId>56d8118bea6cf2.64970262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FAE40E0-DE2A-4D36-B40C-D6807AFDCA63</gtr:id><gtr:title>Safety and tolerability of omalizumab.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce5116274f0299dd76651c9f0b32dcbd"><gtr:id>ce5116274f0299dd76651c9f0b32dcbd</gtr:id><gtr:otherNames>Corren J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>13934676575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>842FCFAA-A5CE-403A-9D95-A0A5B703148A</gtr:id><gtr:title>Association of asthma with a functional promoter polymorphism in the IL16 gene.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fe4c7228de12c6532b01b0d7dd6591d"><gtr:id>9fe4c7228de12c6532b01b0d7dd6591d</gtr:id><gtr:otherNames>Burkart KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>16A888A3A33</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A61197F-BE9B-4DA9-A248-B9C9E113172E</gtr:id><gtr:title>Using genetics to predict the natural history of asthma?</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28951db76a9f81ac234722613fce9583"><gtr:id>28951db76a9f81ac234722613fce9583</gtr:id><gtr:otherNames>Holloway JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>kiJB56JRer6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01811897-48D5-438C-B958-4618666D4D1E</gtr:id><gtr:title>The acetaminophen enigma in asthma.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>bzyQ56VxhCt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>550C9825-3930-41CC-B32E-A98409BBDC9E</gtr:id><gtr:title>Viruses and bacteria in acute asthma exacerbations--a GA&amp;sup2; LEN-DARE systematic review.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9261094ff758ad30fd707b1eebf79713"><gtr:id>9261094ff758ad30fd707b1eebf79713</gtr:id><gtr:otherNames>Papadopoulos NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>BNwE9n9GYPy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3A53B9D-FC9C-48E3-A73E-2B62EBFAA5F4</gtr:id><gtr:title>Pathogenesis of asthma.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>EEE67BF3F95</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CC789BE-E9BE-4695-919F-065459A68090</gtr:id><gtr:title>Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95863687bb1f6112d0742a9ecfcfca46"><gtr:id>95863687bb1f6112d0742a9ecfcfca46</gtr:id><gtr:otherNames>Uller L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>aHZ6GH6hxXt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E78A29D-7021-4B8F-A048-E72AE5695BDC</gtr:id><gtr:title>Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdb919fc36ca86fe4d9d3007a67a749f"><gtr:id>fdb919fc36ca86fe4d9d3007a67a749f</gtr:id><gtr:otherNames>Bjornsdottir US</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>DjGC5hQnLg3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4914B9A7-BAC7-4D04-868A-574561FD4A78</gtr:id><gtr:title>The sound of death rattle II: how do relatives interpret the sound?</gtr:title><gtr:parentPublicationTitle>Palliative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2fa5fdbd216cfaf454572b93a1f51d9"><gtr:id>b2fa5fdbd216cfaf454572b93a1f51d9</gtr:id><gtr:otherNames>Wee BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0269-2163</gtr:issn><gtr:outcomeId>634BA5E7E29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A80C4A9-B3D9-4A09-8876-E977E9F9F431</gtr:id><gtr:title>Effect of bronchoconstriction on airway remodeling in asthma.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b31ee767a89f08cb389e49db9b828f4"><gtr:id>6b31ee767a89f08cb389e49db9b828f4</gtr:id><gtr:otherNames>Grainge CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>gn3Swp5Ku4n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D40A1E42-CFDA-457B-9EDF-4695D88FEAE9</gtr:id><gtr:title>Defective epithelial barrier function in asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e37f05764773d9c16e68bf333724416c"><gtr:id>e37f05764773d9c16e68bf333724416c</gtr:id><gtr:otherNames>Xiao C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>iDfJMXjbQ8F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0843C7C1-BD7E-49DD-B207-2C9E5CD69557</gtr:id><gtr:title>A look at the pathogenesis of asthma: the need for a change in direction.</gtr:title><gtr:parentPublicationTitle>Discovery medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1539-6509</gtr:issn><gtr:outcomeId>H7jmXAXnXX8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDEBC515-B0FE-4CBA-8CBB-C75C2824A720</gtr:id><gtr:title>Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abbe7cdb5259428cb701b33c8f0a8951"><gtr:id>abbe7cdb5259428cb701b33c8f0a8951</gtr:id><gtr:otherNames>James AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>58bd7b5b653e62.28470101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A746F04-E458-4405-83A6-49BC4F2AAF33</gtr:id><gtr:title>An inflammation-independent contraction mechanophenotype of airway smooth muscle in asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/972eda69b764ce94df35724fd7edb99e"><gtr:id>972eda69b764ce94df35724fd7edb99e</gtr:id><gtr:otherNames>An SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58bd7b5b2dd3d6.96842051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65E76FA1-FB6E-47A0-A034-E9D6A3F15FDB</gtr:id><gtr:title>Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions.</gtr:title><gtr:parentPublicationTitle>Journal of evaluation in clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/066a57d964c4b229c2c5dad263eb84c0"><gtr:id>066a57d964c4b229c2c5dad263eb84c0</gtr:id><gtr:otherNames>Elwyn G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1356-1294</gtr:issn><gtr:outcomeId>E9xo5w336rG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A053AED-16BF-4327-BCAA-C4D59F1309D4</gtr:id><gtr:title>Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell metaplasia and Th2 inflammation.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89d7a566700b631a113c361e9329c959"><gtr:id>89d7a566700b631a113c361e9329c959</gtr:id><gtr:otherNames>Maeda Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>aeZGu1zbm1N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7219802-F9FA-4C23-B81A-FB537433D4D0</gtr:id><gtr:title>A brief history of asthma and its mechanisms to modern concepts of disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Allergy, asthma &amp; immunology research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>2092-7355</gtr:issn><gtr:outcomeId>FXvLrSN384m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEE33CFD-B173-43A7-B551-47A440166888</gtr:id><gtr:title>Exogenous IFN-? has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdf236abadd59c50f2a6319fb59a6457"><gtr:id>bdf236abadd59c50f2a6319fb59a6457</gtr:id><gtr:otherNames>Cakebread JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>ge7NH9CDKLH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>046341E2-CD8A-458B-A916-37AFA4FA588E</gtr:id><gtr:title>The ever-expanding ERS fellowship programmes: achievements over the past 3 years.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>58bd7b5af12710.29378530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8D5883A-05F5-407B-A05D-97434E07E7F1</gtr:id><gtr:title>Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches?</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>PK6qsuaMfnC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EE10623-7614-449F-8038-ABF07AE736D6</gtr:id><gtr:title>Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28e2aaa042119fd9e5c792ae25ea51f3"><gtr:id>28e2aaa042119fd9e5c792ae25ea51f3</gtr:id><gtr:otherNames>Brozek JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pY8LRZRsZct</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>331B6E9D-899E-41BE-91C4-0B014CD927C8</gtr:id><gtr:title>The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.</gtr:title><gtr:parentPublicationTitle>Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8f20eb6bfab779a8c8dcd93bc1d208b"><gtr:id>c8f20eb6bfab779a8c8dcd93bc1d208b</gtr:id><gtr:otherNames>Holgate S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-6111</gtr:issn><gtr:outcomeId>440050CB1A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3DDC117-D03F-4D2D-A82C-E2A1762EC52E</gtr:id><gtr:title>Is artificial fluoride absorbed to the same extent as natural fluoride?</gtr:title><gtr:parentPublicationTitle>Journal of dental research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e93b23dbce89836afcc74639abbc269"><gtr:id>0e93b23dbce89836afcc74639abbc269</gtr:id><gtr:otherNames>Sheldon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-0345</gtr:issn><gtr:outcomeId>E4C1CF0610C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA359058-590D-4052-BF45-7C03C07284EC</gtr:id><gtr:title>Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>bzak4rvPYJC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C64188A8-A54C-477D-BE59-68E274B7E5E8</gtr:id><gtr:title>Has the time come to rethink the pathogenesis of asthma?</gtr:title><gtr:parentPublicationTitle>Current opinion in allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1473-6322</gtr:issn><gtr:outcomeId>BDDA7AD69A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66D6B4A7-37AE-42E2-A36A-52B1AF9FEA5E</gtr:id><gtr:title>Mechanical Strain Causes Adaptive Change in Bronchial Fibroblasts Enhancing Profibrotic and Inflammatory Responses.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df6218fdbbdd96ccbd9e67e22d1b5ae3"><gtr:id>df6218fdbbdd96ccbd9e67e22d1b5ae3</gtr:id><gtr:otherNames>Manuyakorn W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d506324eb14.76902002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B2ADA6D-BC27-4A8D-91A0-8649044EB1D4</gtr:id><gtr:title>Soluble ADAM33 initiates airway remodeling to promote susceptibility for allergic asthma in early life.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08b5309dde4cf0034e1f18ad3741e703"><gtr:id>08b5309dde4cf0034e1f18ad3741e703</gtr:id><gtr:otherNames>Davies ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>58bd77f0d22c69.85522806</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D07C54DA-5B02-4129-A50E-B5D9D365C2E1</gtr:id><gtr:title>Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9261094ff758ad30fd707b1eebf79713"><gtr:id>9261094ff758ad30fd707b1eebf79713</gtr:id><gtr:otherNames>Papadopoulos NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>95B14134847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFA379F4-FCFF-43EF-BEDF-DA67A7DD2639</gtr:id><gtr:title>Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b97a74ae9b08d844a34f7dcd4794355"><gtr:id>2b97a74ae9b08d844a34f7dcd4794355</gtr:id><gtr:otherNames>Church MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>UELYeiuS99M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99BE506E-3FFA-40A3-9747-A60C647C1648</gtr:id><gtr:title>The sentinel role of the airway epithelium in asthma pathogenesis.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>bCUDmSRkR6v</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDE594F8-BF54-4079-AEC5-D1DC7AA71DB1</gtr:id><gtr:title>Chronic fatigue syndrome: understanding a complex illness.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn><gtr:outcomeId>fAraMJN7577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D678BDDF-E89B-4796-B3F7-7675225CB5AA</gtr:id><gtr:title>'Every breath we take: the lifelong impact of air pollution' - a call for action.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>58bd7a14f0db54.75405194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDE88CBE-4666-4BC9-9FFC-32D9A1E49DB9</gtr:id><gtr:title>Identification of ATPAF1 as a novel candidate gene for asthma in children.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62d95966785cc7fc6a25dfb9d6043b3b"><gtr:id>62d95966785cc7fc6a25dfb9d6043b3b</gtr:id><gtr:otherNames>Schauberger EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>BLYR2UomB64</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEAF2945-BABD-42EC-B847-B8EAFB081038</gtr:id><gtr:title>Fluoridation: Interpreting the Newcastle fluoride bioavailability study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>A4C37CCB05F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF3164AC-03F0-4ADA-9AD4-1CEC458A6118</gtr:id><gtr:title>ADAM metallopeptidase domain 33 (ADAM33): identification and role in airways disease.</gtr:title><gtr:parentPublicationTitle>Drug news &amp; perspectives</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0214-0934</gtr:issn><gtr:outcomeId>gcWnx8fuKnn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D640DF8-955C-4B63-A040-FDE428E770AC</gtr:id><gtr:title>The Brussels Declaration: the need for change in asthma management.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8f20eb6bfab779a8c8dcd93bc1d208b"><gtr:id>c8f20eb6bfab779a8c8dcd93bc1d208b</gtr:id><gtr:otherNames>Holgate S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>2AACD047E66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B14B035E-B100-4E75-902B-035EF1750E9F</gtr:id><gtr:title>The sound of death rattle I: are relatives distressed by hearing this sound?</gtr:title><gtr:parentPublicationTitle>Palliative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2fa5fdbd216cfaf454572b93a1f51d9"><gtr:id>b2fa5fdbd216cfaf454572b93a1f51d9</gtr:id><gtr:otherNames>Wee BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0269-2163</gtr:issn><gtr:outcomeId>BFDCB5A2966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EAE1C39-D924-46E8-A935-1631E9554BF9</gtr:id><gtr:title>Animal models of asthma: value, limitations and opportunities for alternative approaches.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b01479ccde68d4bd2d975a6ce3e4dfb9"><gtr:id>b01479ccde68d4bd2d975a6ce3e4dfb9</gtr:id><gtr:otherNames>Holmes AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>bPyJeEKLo4i</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EF63B28-BB5D-4EC6-9076-66C979F54356</gtr:id><gtr:title>CD48 on blood leukocytes and in serum of asthma patients varies with severity.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fdcb6f72e93dae9c485e5692c1db936"><gtr:id>0fdcb6f72e93dae9c485e5692c1db936</gtr:id><gtr:otherNames>Gangwar RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>58bd7a1577c3e1.43152230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39180FAC-1930-4102-9D88-E384A75BC634</gtr:id><gtr:title>Effects of omalizumab on markers of inflammation in patients with allergic asthma.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8f20eb6bfab779a8c8dcd93bc1d208b"><gtr:id>c8f20eb6bfab779a8c8dcd93bc1d208b</gtr:id><gtr:otherNames>Holgate S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>730BFD88D58</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G19/34</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>200</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>200</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>